We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Effects of Losartan and Antiretroviral Regimen Containing Raltegravir in Fibrosis Inflammation Mediators, Cardiovascular Risk and Neurocognitive Disorders in HIV Infected Patients Previously Effectively Treated

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01529749
Recruitment Status : Completed
First Posted : February 9, 2012
Last Update Posted : February 19, 2016
Information provided by (Responsible Party):
Felipe Garcia, Hospital Clinic of Barcelona

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : March 2012
  Study Completion Date : January 2015